| 000 | 01709 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514163135.0 | ||
| 264 | 0 | _c20041119 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a0960-8931 | ||
| 024 | 7 |
_a10.1097/00008390-200312000-00012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGlover, Donna | |
| 245 | 0 | 0 |
_aPhase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanoma: an Eastern Cooperative Oncology Group Study (E1686). _h[electronic resource] |
| 260 |
_bMelanoma research _cDec 2003 |
||
| 300 |
_a619-26 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmifostine _xadministration & dosage |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypotension |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aRadiation-Protective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aIbrahim, Joseph | |
| 700 | 1 | _aKirkwood, John | |
| 700 | 1 | _aGlick, John | |
| 700 | 1 | _aKarp, Daniel | |
| 700 | 1 | _aStewart, James | |
| 700 | 1 | _aEwell, Marian | |
| 700 | 1 | _aBorden, Ernest | |
| 773 | 0 |
_tMelanoma research _gvol. 13 _gno. 6 _gp. 619-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00008390-200312000-00012 _zAvailable from publisher's website |
| 999 |
_c14381211 _d14381211 |
||